Aemetis (NASDAQ:AMTX) Stock Sees Unusually High Call Option Buying

Aemetis, Inc (NASDAQ:AMTX) saw some unusual options trading activity on Monday. Stock traders purchased 6,674 call options on the stock. This represents an increase of approximately 316% compared to the typical volume of 1,605 call options.

Analysts Set New Price Targets

AMTX has been the topic of a number of research analyst reports. Weiss Ratings reiterated a “sell (e+)” rating on shares of Aemetis in a research report on Friday, July 17th. Wall Street Zen raised Aemetis from a “sell” rating to a “hold” rating in a research report on Saturday, August 22nd. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, Aemetis has an average rating of “Hold” and a consensus target price of $11.88.

Hedge Funds Weigh In On Aemetis

A number of hedge funds and other institutional investors have recently made changes to their positions in AMTX. Bank of New York Mellon Corp purchased a new stake in shares of Aemetis in the second quarter valued at about $283,000. Bank of America Corp DE raised its holdings in Aemetis by 148.3% during the first quarter. Bank of America Corp DE now owns 101,486 shares of the specialty chemicals company’s stock worth $324,000 after purchasing an additional 60,611 shares in the last quarter. Royal Bank of Canada raised its holdings in Aemetis by 10,632.5% during the first quarter. Royal Bank of Canada now owns 8,908 shares of the specialty chemicals company’s stock worth $28,000 after purchasing an additional 8,825 shares in the last quarter. Renaissance Technologies LLC acquired a new stake in Aemetis in the first quarter valued at about $272,000. Finally, Sanctuary Advisors LLC acquired a new stake in Aemetis in the first quarter valued at about $33,000. Hedge funds and other institutional investors own 27.02% of the company’s stock.

Aemetis Price Performance

Shares of Aemetis stock opened at $1.83 on Wednesday. The firm’s fifty day simple moving average is $1.80 and its 200-day simple moving average is $2.15. Aemetis has a 12 month low of $1.30 and a 12 month high of $3.80. The stock has a market capitalization of $132.07 million, a price-to-earnings ratio of -2.01 and a beta of 1.47.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings results on Thursday, August 6th. The specialty chemicals company reported ($0.13) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.29) by $0.16. The business had revenue of $62.70 million for the quarter, compared to analyst estimates of $67.69 million. Analysts anticipate that Aemetis will post -0.89 earnings per share for the current year.

About Aemetis

Aemetis, Inc is a renewable fuels and biochemicals company focused on developing and operating technologies that reduce greenhouse gas emissions. Its activities include the production of renewable natural gas, renewable fuels, and other low-carbon products derived from agricultural and organic waste.

The company’s Aemetis Biogas business develops and operates dairy-waste digesters and related infrastructure in California’s Central Valley. These systems capture methane from dairy manure and convert it into renewable natural gas for transportation and other energy applications.